0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroesophageal Reflux Disease (GERD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Ulcerative Colitis - Pipeline Insight, 2025 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
EUR$3,000USDGBP
Hemorrhoids - Pipeline Insight, 2025 - Product Thumbnail Image

Hemorrhoids - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Severe Hypoglycemia - Pipeline Insight, 2025 - Product Thumbnail Image

Severe Hypoglycemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Short Bowel Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Short Bowel Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Lipodystrophy Syndrome (LS) - Pipeline Insight, 2025 - Product Thumbnail Image

Lipodystrophy Syndrome (LS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Oral Mucositis - Pipeline Insight, 2025 - Product Thumbnail Image

Oral Mucositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
EUR$1,500USDGBP
Pancreatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Pancreatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Traveler's Diarrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Traveler's Diarrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Peptic Ulcer - Pipeline Insight, 2025 - Product Thumbnail Image

Peptic Ulcer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Ascites - Pipeline Insight, 2025 - Product Thumbnail Image

Ascites - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Anal Fissure - Pipeline Insight, 2025 - Product Thumbnail Image

Anal Fissure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Gastric Ulcers - Pipeline Insight, 2025 - Product Thumbnail Image

Gastric Ulcers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Fecal Incontinence - Pipeline Insight, 2025 - Product Thumbnail Image

Fecal Incontinence - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Eosinophilic Esophagitis- Pipeline Insight, 2025 - Product Thumbnail Image

Eosinophilic Esophagitis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Duodenal Ulcer - Pipeline Insight, 2025 - Product Thumbnail Image

Duodenal Ulcer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Diabetic Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Emesis- Pipeline Insight, 2025 - Product Thumbnail Image

Emesis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
EUR$1,500USDGBP
Dyspepsia- Pipeline Insight, 2025 - Product Thumbnail Image

Dyspepsia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more